FDA — authorised 22 December 1967
- Application: NDA016269
- Marketing authorisation holder: HOSPIRA
- Local brand name: MANNITOL 25%
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Aridol Kit on 22 December 1967
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 22 December 1967; FDA authorised it on 11 August 1972; FDA authorised it on 29 August 1975.
HOSPIRA holds the US marketing authorisation.